Literature DB >> 384857

Candida tropicalis: a major pathogen in immunocompromised patients.

J R Wingard, W G Merz, R Saral.   

Abstract

Of 89 consecutive patients undergoing treatment for hematologic malignancies or undergoing allogeneic bone marrow transplantation, 60 were colonized with Candida albicans and 25 with C. tropicalis. However, of the 18 disseminated infections caused by Candida species, 15 infections in 14 patients were caused by C. tropicalis and only three infections in three patients by C. albicans. The setting in which the infection occurred, skin lesions, polyarthralgias, or polymyalgias, and the unexplained deterioration of renal function were features suggestive of the diagnosis. Defervescence occurred in 10 of the 14 treated patients with C. tropicalis infections in 1 to 6 d (mean, 2.5 d) after initiation of therapy, even though all continued to be granulocytopenic. Resolution occurred in eight of the 15 C. tropicalis infections. In one case outcome was indeterminate, four patients died due to the infection, and two died from other causes but with the infection unresolved.

Entities:  

Mesh:

Year:  1979        PMID: 384857     DOI: 10.7326/0003-4819-91-4-539

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  57 in total

Review 1.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

2.  Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

Authors:  C P Girish Kumar; Ahmed Medhat Hanafy; Masakazu Katsu; Yuzuru Mikami; Thangam Menon
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

3.  Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies.

Authors:  J C García-Ruiz; M del Carmen Arilla; P Regúlez; G Quindós; A Alvarez; J Pontón
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Development of an integrative DNA transformation system for the yeast Candida tropicalis.

Authors:  L O Haas; J M Cregg; M A Gleeson
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

6.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Candida tropicalis infection in normal, diabetic, and neutropenic mice.

Authors:  R A Fromtling; G K Abruzzo; D M Giltinan
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Fungal colonization in patients with cancer of the upper respiratory tract.

Authors:  V Vidotto; M Clerico; L Franzin; L Lucchini; A Sinicco
Journal:  Mycopathologia       Date:  1986-11       Impact factor: 2.574

9.  Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Authors:  Emmanuel Roilides; Evangelia Farmaki; Joanna Evdoridou; Andrea Francesconi; Miki Kasai; Joanna Filioti; Maria Tsivitanidou; Danai Sofianou; George Kremenopoulos; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.

Authors:  D G Ahearn; M S McGlohn
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.